JP2009051812A5 - - Google Patents

Download PDF

Info

Publication number
JP2009051812A5
JP2009051812A5 JP2008128074A JP2008128074A JP2009051812A5 JP 2009051812 A5 JP2009051812 A5 JP 2009051812A5 JP 2008128074 A JP2008128074 A JP 2008128074A JP 2008128074 A JP2008128074 A JP 2008128074A JP 2009051812 A5 JP2009051812 A5 JP 2009051812A5
Authority
JP
Japan
Prior art keywords
xrpd
powder
formula
hydroxydiphenylmethyl
oxobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008128074A
Other languages
English (en)
Other versions
JP2009051812A6 (ja
JP2009051812A (ja
JP5342169B2 (ja
Filing date
Publication date
Priority claimed from IT000987A external-priority patent/ITMI20070987A1/it
Application filed filed Critical
Publication of JP2009051812A publication Critical patent/JP2009051812A/ja
Publication of JP2009051812A6 publication Critical patent/JP2009051812A6/ja
Publication of JP2009051812A5 publication Critical patent/JP2009051812A5/ja
Application granted granted Critical
Publication of JP5342169B2 publication Critical patent/JP5342169B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

式(I)の得られたケト:4−{[4−(4−ヒドロキシジフェニルメチル)−1−ピペリジニル]−1−オキソブチル}−α,α−ジメチルベンゼン酢酸は、XRPD(ここで、最も強い回折ピークが、2θにおいて5.7;8.8;10.3;11.5;16.1;17.3;18.1;19.4;20.0;22.8±0.2°である)を有する結晶構造を有する。前記結晶形態の式(I)のケトンは、新規化合物であり、本発明の目的物である。
本発明の新規形態は、通常のXRPD技術(粉末X線回折)で特徴付けられた。X線回折スペクトル(XRPD)を、粉末および液体(イタル−構造)に対して自動回折計で次の操作条件:CuKα放射線(λ=1.5418Å)、角度ステップ0.04°で3秒間の走査下で記録した。 式(I)の化合物のXRPD(粉末X線回折)回折図形を、最も強い回折ピークが、2θにおいて5.7;8.8;10.3;11.5;16.1;17.3;18.1;19.4;20.0;22.8±0.2°である図で報告される。

Claims (1)

  1. 最も強い回折ピークが、2θにおいて5.7;8.8;10.3;11.5;16.1;17.3;18.1;19.4;20.0;22.8±0.2°であるXRPDを有する結晶形態にある、4−{[4−(4−ヒドロキシジフェニルメチル)−1−ピペリジニル]−1−オキソブチル}−α,α−ジメチルベンゼン酢酸。
JP2008128074A 2007-05-16 2008-05-15 ケト化合物の製法 Expired - Fee Related JP5342169B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2007A000987 2007-05-16
IT000987A ITMI20070987A1 (it) 2007-05-16 2007-05-16 Procedimento per la preparazione di composti chetonici

Publications (4)

Publication Number Publication Date
JP2009051812A JP2009051812A (ja) 2009-03-12
JP2009051812A6 JP2009051812A6 (ja) 2009-06-18
JP2009051812A5 true JP2009051812A5 (ja) 2011-05-26
JP5342169B2 JP5342169B2 (ja) 2013-11-13

Family

ID=39666057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008128074A Expired - Fee Related JP5342169B2 (ja) 2007-05-16 2008-05-15 ケト化合物の製法

Country Status (9)

Country Link
US (1) US8236961B2 (ja)
EP (1) EP1992615B1 (ja)
JP (1) JP5342169B2 (ja)
AT (1) ATE554068T1 (ja)
AU (1) AU2008202097A1 (ja)
BR (1) BRPI0801557A2 (ja)
CA (1) CA2631376A1 (ja)
IL (1) IL191460A0 (ja)
IT (1) ITMI20070987A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2403130B1 (es) * 2010-06-15 2014-09-29 Chemelectiva S.R.L. Forma polimórfica de clorhidrato de fexofenadina, compuestos intermedios y procedimiento para su preparación
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
MX9302076A (es) 1992-04-10 1994-03-31 Merrell Dow Pharma Proceso novedoso para preparar derivados de piperidina.
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
ITRM20010260A1 (it) * 2001-05-17 2002-11-18 Dinamite Dipharma S P A In For Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz
JP2005537218A (ja) * 2001-11-08 2005-12-08 テバ ファーマシューティカル インダストリーズ リミティド フェキソフェナジン塩基の多形体
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
ITMI20041143A1 (it) * 2004-06-08 2004-09-08 Dipharma Spa Polimorfi di fexofenadina e procedimento per la loro preparazione
EP1616861A3 (en) 2004-06-15 2006-02-08 Dipharma S.p.A. A process for the preparation of keto compounds
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法

Similar Documents

Publication Publication Date Title
WO2009028553A1 (ja) チタン酸化合物及びその製造方法並びに該チタン酸化合物を含む電極活物質、電極活物質を用いてなる蓄電デバイス
JP2009520765A5 (ja)
EP1667971B1 (en) Fexofenadine polymorphs and processes of preparing the same
JP2010533203A5 (ja)
JP2010533191A5 (ja)
JP2010521514A5 (ja)
RU2011107128A (ru) Новая молекулярно-ситовая композиция емм-12, способы ее получения и применения
BRPI0617506A2 (pt) derivados de Ácido dicarboxÍlico e seu uso
JP2009051812A5 (ja)
JP2009521414A5 (ja)
JP2010265452A5 (ja) 顔料の製造方法
JP2010511649A5 (ja)
Khandavilli et al. High solubility crystalline hydrates of Na and K furosemide salts
JP2012533550A5 (ja)
JP2021514967A5 (ja)
JP2013503145A5 (ja)
JP2009541344A5 (ja)
BG108435A (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
JPWO2020037164A5 (ja)
RU2008105987A (ru) Новые пиперидиновые производные
US20050277775A1 (en) Process for the preparation of keto compounds
JP2016503041A5 (ja)
WO2007146768A3 (en) Compounds for the treatment of metabolic disorders
JP7252978B2 (ja) 2-(1-(tert-ブトキシカルボニル)ピペリジン-4-イル)安息香酸を調製するためのプロセス
EP1992615B1 (en) A process for the preparation of keto compounds